The European Medicines Agency has appointed rapporteurs for the evaluation of the Russian Sputnik V coronavirus vaccine and its developers are “waiting for EMA to begin the rolling review and announce it officially on its web site,” according to the Russian Direct Investment Fund, which is financing the development of the vaccine.
Sputnik V Vaccine Team ‘Working With EMA To Start Rolling Review’
After a few false starts, it seems that the EU regulator has begun preparing the ground for a review of Russia’s adenovirus-based COVID-19 vaccine.
More from Europe
More from Geography
• By
Europe’s vaccines industry wants to make sure immunizations “are not forgotten” by policymakers who are overseeing the EU Health Technology Assessment Regulation. It has highlighted several nuances of vaccines that should be addressed over the coming years.
• By
A new chapter that will be published in the European Pharmacopoeia soon is expected to provide a comprehensive framework for the production and quality control of cell-based preparations. Meanwhile, an existing chapter has been revised to facilitate the implementation of rapid microbiological testing methods.
• By
The preliminary White House 2026 budget plan cuts agency funding, but not so sharply that user fees are excluded from collection.